Clinical Impact of Switching to Ceritinib After Severe AEs Related to Crizotinib/Alectinib in a Novel PTH2R-ALK Fusion Lung Adenocarcinoma: A Case Report

Lung cancer is still the leading cause of morbidity and mortality by cancer among men, according to the latest epidemiological data in China. Anaplastic lymphoma kinase (ALK) rearrangements act as key oncogenic drivers of non-small cell lung cancer (NSCLC) and have been identified in 5–6% of NSCLC....

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Gang, Du, Yinping, Shen, Jifang, Zhang, Junling, Xia, Xihua, Huang, Mengli, Shen, Wenxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8711735/
https://www.ncbi.nlm.nih.gov/pubmed/34992382
http://dx.doi.org/10.2147/OTT.S340984

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8711735/
https://www.ncbi.nlm.nih.gov/pubmed/34992382
http://dx.doi.org/10.2147/OTT.S340984

Ejemplares similares